Understanding Fish Consumption Habits During Pregnancy

Nutrition Clinical Trial

Official title:

A Qualitative Study of Fish Consumption During Pregnancy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01178398
• Other study ID #: 0613
• Secondary ID: P30ES000002
• Status: Completed
• Phase: N/A
• First received: August 3, 2010
• Last updated: August 9, 2010
• Start date: October 2009
• Est. completion date: March 2010

Study information

• Verified date: August 2010
• Source: Harvard Pilgrim Health Care
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Many pregnant women in the US do not consume enough docosahexaenoic acid (DHA), an essential nutrient found in fish. Apparently conflicting findings that fish consumption is beneficial for the developing fetus, yet potentially toxic because of mercury contamination, have created uncertainty about the appropriate fish consumption advice to provide pregnant women. The investigators objective was to determine knowledge, behaviors, and received advice regarding fish consumption among pregnant women who are infrequent consumers of fish.

Description:

Fish is a healthful food that is the primary dietary source of elongated n-3 polyunsaturated fatty acids (PUFA), nutrients essential for optimal neurodevelopment. Most pregnant women in the US do not consume adequate n-3 PUFA. However, fish also may be contaminated with methylmercury, and approximately 10% of women of childbearing age in the US have mercury levels higher than recommended. Because the same food contains both essential nutrients and harmful contaminants, substantial confusion reigns about the best course of action for pregnant women. Additionally, it is not clear what fish consumption advice would be most effective in changing women's fish consumption habits. The goal of this pilot study is to perform formative work to allow us to develop and refine an intervention to promote consumption of fish low in mercury and high in n-3 PUFA among pregnant women. This project, together with a pilot RCT already funded, will serve as preliminary data to support a larger RCT to evaluate the effects of the intervention on pregnancy outcomes and postpartum maternal and infant health.

Specific Aims Aim 1. Among pregnant women, identify: 1) knowledge of the potential risks and benefits associated with fish consumption during pregnancy; 2) awareness of current recommendations for fish consumption by pregnant women; 3) the sources of information from which they are learning about the health effects associated with fish intake; and 4) facilitators and barriers to fish consumption, such as cost, availability, taste, and habits. To achieve this aim, we will conduct focus groups with pregnant women in the Boston area who are infrequent consumers of fish (defined as <= 2 monthly fish servings).

Aim 2. Develop materials for a planned intervention to increase consumption of fish high in n-3 polyunsaturated fatty acids and low in methylmercury among pregnant women who are infrequent consumers of fish at baseline. We will use results from Aim 1 to inform the development of these materials.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 22
• Est. completion date: March 2010
• Est. primary completion date: March 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• currently pregnant

• age at least 18 years

Exclusion Criteria:

• unable to speak or understand English

• consuming 2 or more weekly fish servings

• unable to eat fish (e.g. allergy, dietary restriction)

Study Design

Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Nutrition

Locations

Country	Name	City	State
United States	Harvard Pilgrim Health Care Institute	Boston	Massachusetts

Sponsors (3)

Lead Sponsor	Collaborator
Harvard Pilgrim Health Care	HSPH-NIEHS Center for Environmental Health, National Institute of Environmental Health Sciences (NIEHS)

Country where clinical trial is conducted

United States,